Bristol-Myers has suspended its study of a drug intended to treat liver disease hepatitis C after a patient suffered heart failure.
WSJ.com: What's News US, Wall Street Journal
Thu, 08/02/2012 - 5:40am
Bristol-Myers has suspended its study of a drug intended to treat liver disease hepatitis C after a patient suffered heart failure.